GlassScriptPhysician profile
Bradley A Colman
NPI 1972593176
$4,608.49
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $1,193 · 2021: $1,650 · 2022: $534.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $804.29 | 2019-2022 | |
| Abbvie INC. | $643.64 | 2019-2022 | |
| Novo Nordisk INC | $475.93 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $450.87 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $341.51 | 2019-2021 | |
| Lilly USA, LLC | $208.70 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.40 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $188.48 | 2019-2022 | |
| Allergan, INC. | $170.84 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $147.21 | 2021 | |
| Pfizer INC. | $116.06 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.65 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $106.60 | 2019-2022 | |
| Abbott Laboratories | $97.23 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $86.43 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $79.77 | 2019 | |
| Amarin Pharma, INC. | $78.77 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $41.90 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $41.57 | 2019-2022 | |
| Edwards Lifesciences Corporation | $40.07 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.28 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.86 | 2019-2022 | |
| Dexcom, INC. | $28.94 | 2021 | |
| Glaxosmithkline, LLC. | $27.75 | 2021 | |
| Astellas Pharma US INC | $23.82 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.39 | 2020 | |
| Currax Pharmaceuticals LLC | $12.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.65 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Colman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.